ruxolitinib,pelabresib
incyte,novartis,morphosys
['mpnsm', 'ruxolitinib', 'prince', 'fedratinib', '#mpn', '#myelof']
congress | #eha2022 | , princess margaret cancer center, presented matching-adjusted indirect comparison for svr35 and tss50 outcomes of pelabresib combined with ruxolitinib vs ruxolitinib or fedratinib monotherapy in intermediate or high-risk #myelofibrosis #mpnsm 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm